Events | CRIS – Consortium for Clinical Research & Innovation Singapore

Gene Modification Therapies for In Utero Treatment of Hereditary Diseases

Gene Modification Therapies for In Utero Treatment of Hereditary Diseases

Explore the concept of in utero therapy of genetic diseases, as well as the concepts and potential benefits of a prenatal approach. A/Prof Mattar will also describe the progress in the field using specific disease models, and address the limitations, potential complications and challenges to clinical translation.

CRIS Scientific Symposium 2022 – Advancing Clinical Research and Innovation in Singapore

22February 2022

CRIS Scientific Symposium 2022 – Advancing Clinical Research and Innovation in Singapore

Thank you for joining us at the CRIS Official Launch and inaugural CRIS Scientific Symposium on 6 April 2022. Click here to catch up on the event highlights and key sessions.

Cultured Epithelial Autografts: Clinical Applications and Optimising the Cell Culture System

21February 2022

Cultured Epithelial Autografts: Clinical Applications and Optimising the Cell Culture System

A/Prof Alvin Chua and his team recently developed a robust fully human and chemically defined system with the use of biologically-relevant laminins – proteins from the basement membrane – to culture skin keratinocytes and their stem cells. They are preparing for a first-in-human clinical trial to test the safety and efficacy with this newly developed method. While CEA is a known useful modality for the reconstruction of extensive skin defects, they are hopeful that this new xeno-free and defined culture method can find broader use in the treatment of smaller burns and chronic wounds.

Progress and Challenges in Retinal Cell Therapy for Vision Regeneration

15February 2022

Progress and Challenges in Retinal Cell Therapy for Vision Regeneration

This talk will cover work by Dr Su’s retinal translational therapeutics lab on retinal stem cell transplants in non-human primate models. She will also discuss the development of unique stem cell resources in collaboration with industry partners, including efforts to translate retinal stem cell therapy into an effective treatment for retinal degenerative diseases.

Innate Immune Cells in Cancer Immunotherapy

15February 2022

Innate Immune Cells in Cancer Immunotherapy

This talk will discuss the clinical development in NK and γδ T-cell immunotherapy and pre-clinical efforts to enhance their therapeutic efficacies.

Cell Therapy in Myeloma – Current Evidence and Future Perspectives

17November 2021

Cell Therapy in Myeloma – Current Evidence and Future Perspectives

Join Dr Chandramouli Nagarajan, Senior Consultant Haematologist at the Singapore General Hospital, to review the current use of Chimeric Antigen Receptor (CAR) T-cell therapy in Myeloma and its results. Dr Chandramouli will also discuss the future role of CAR-T therapy during the webinar.

SWITCH 2021 – Future of Biotech

SWITCH 2021 – Future of Biotech

Explore the advancements that science is making in cell and gene therapy, what that means for patients globally, and what it will take to bring these therapies to market.

Side Effects of CAR-T Treatment and Management

Side Effects of CAR-T Treatment and Management

Chimeric Antigen Receptor (CAR) treatment has given hope to many patients who would otherwise succumb to their relapsed/refractory diseases. However, this new therapy is often associated with significant toxicities, leading to morbidities and even mortalities occasionally. This talk focuses on the common side effects of CAR-T therapy as well as the early recognition and management of these side effects.

$Current Challenges in the Treatment of Relapsed/Refractory Malignant Haematological Conditions$

21September 2021

Current Challenges in the Treatment of Relapsed/Refractory Malignant Haematological Conditions

Join this webinar to review the management of patients with relapsed/refractory malignancies and look at the growing role of precision and personalised medicine in the management of these patients. With a focus on the Singapore context, the talk aims to highlight the current challenges faced and how these have been addressed to optimise care for patients.

Precision Healthcare for the Population

21September 2021

Precision Healthcare for the Population

Join us in this webinar, where we have experts from various agencies looking into developing a more robust Precision Health infrastructure on the population level. Understand the challenges within Precision Health, and take a glimpse into the future of healthcare with population health programmes.

Role of Current Stem Cell Therapy for Malignant Haematology

Role of Current Stem Cell Therapy for Malignant Haematology

In this webinar, Dr Francesca Lorraine Lim will give a brief overview of the types of stem cell-based therapies, with a focus on the use of haematopoietic stem cell transplantation to treat blood cancers.

Practical Considerations in Delivering CAR-T Cell Therapies in Singapore

Practical Considerations in Delivering CAR-T Cell Therapies in Singapore

In this webinar, Dr Chen Yunxin will share insights from her time at the Memorial Sloan Kettering Cancer Center, a pioneering and renowned institute in the delivery of CAR T-cell therapy, and how this therapy can be applied to and implemented in the local context.

Regenerative Medicine for Parkinson’s Disease

Regenerative Medicine for Parkinson’s Disease

Join this webinar to find out what are the ongoing efforts in cell-based therapy for Parkinson’s Disease and get an update on Singapore’s efforts in this space that may impact the future of regenerative medicine.

Glycosaminoglycan Bioadditives for the Expansion of Potent Mesenchymal Stem Cells

Glycosaminoglycan Bioadditives for the Expansion of Potent Mesenchymal Stem Cells

This webinar will introduce the work of ASTEM with a focus on the use of cell culture bioadditives that sustain the growth of multipotent MSC over extended passaging.

Singapore’s National Precision Medicine Strategy: Supporting Data-Driven Healthcare

Singapore’s National Precision Medicine Strategy: Supporting Data-Driven Healthcare

Join Professor Patrick Tan, Executive Director of PRECISE, to understand more about Singapore’s National Precision Medicine strategy

The Yin and Yang of Regulatory Science in the Post-COVID Big Data Era

The Yin and Yang of Regulatory Science in the Post-COVID Big Data Era

Presented by SGInnovate and Eureka Institute for Translational Medicine. SingHealth-DukeNUS Academic Medical Centre

CAR-T Translational Opportunities in Paediatric Cancers

CAR-T Translational Opportunities in Paediatric Cancers

Chimeric Antigen Receptor T-cell (CAR-T) therapy has changed the paradigm for the treatment of relapsed or refractory paediatric cancers for patients who have otherwise exhausted all treatment options.

National Precision Medicine Alliance Meeting

National Precision Medicine Alliance Meeting

Sign up for the National Precision Medicine Alliance quarterly meeting to stay updated on the latest developments in Singapore’s precision medicine scene.

SCRI-NHG Clinical Research Coodinator Society Webinar

SCRI-NHG Clinical Research Coodinator Society Webinar

Join this webinar to find out how clinical trials are conducted during the pandemic and celebrate the contributions of Clinical Research Coordinators (CRCs) to the research landscape in Singapore.

CAR-Based Cell Therapies – Scientific Breakthroughs and Manufacturing Innovations

CAR-Based Cell Therapies – Scientific Breakthroughs and Manufacturing Innovations

Join this webinar to learn more about CAR technology, recent ground-breaking pre-clinical and clinical studies, manufacturing innovations.

Cell Therapy – Promises and Challenges

17February 2021

Cell Therapy – Promises and Challenges

Join ACTRIS’ inaugural Cell Therapy Lecture Series to find out more about the advancements and challenges in the field of cell therapy.

Population Genomics Driving Precision Health: Singapore’s National Precision Medicine Programme

17February 2021

Population Genomics Driving Precision Health: Singapore’s National Precision Medicine Programme

Hear about Singapore’s National Precision Medicine Strategy and how Singapore seeks to address the challenges in the clinical implementation of precision medicine approaches and technologies.

Economist’s Future of Healthcare Week Asia

25November 2020

Economist’s Future of Healthcare Week Asia

The Economist’s Future of Healthcare Week Asia took place on November 16th - 20th 2020.

Top